Product News: Ask DX to Diagnose your Lab Logistics and Delivery Needs at IBMS Congress 2013

20 Sep 2013

DX, a leading independent logistics and parcel distribution company operating throughout the UK & Ireland, is to exhibit at next week’s IBMS Biomedical Science Congress, taking place at Birmingham’s ICC.

DX works with some of the largest health organisations in the UK, including BUPA, the National Blood Service and DEFRA, and has a strong reputation for reliability and security built through 30 years of experience in this sector. DX provides a post-5pm collection and pre-9am next-day delivery service, and offers Customers the capability to track every consignment online. In addition, DX supplies and collects all packaging, which is IATA 620/650 approved and fully compliant with the industry’s highest regulations.

The aim of the IBMS Biomedical Science Congress is to advance excellence in biomedical science to ensure that it continues to meet the needs of society. It brings together the best in science and technology and addresses the role of biomedical scientists in the context of the current policies and best practices that are shaping the profession.

Located on Stand 818, in the guise of ‘Delivery Doctors’, DX will be welcoming visitors and senior industry figures by offering a ‘diagnosis’ on how they can best manage their logistics and delivery needs. DX will also be showcasing the latest developments to its secure offering for the health sector, including significant improvements to its Tracked Specimen service: an all-inclusive packaging and delivery solution for Category B specimens.

Paul Doble, Group Sales and Marketing Director, at DX said “The health sector demands extremely high security levels for the transportation and delivery of - what can sometimes be - dangerous and sensitive items. Each consignment must arrive safely, securely and on-time, with patient data being kept private. DX has a wealth of experience in this space and, as such, we will be able to offer invaluable advice to the IBMS Biomedical Science Congress audience.”